Effect of visceral fat accumulation on uric acid metabolism in male obese subjects: Visceral fat obesity is linked more closely to overproduction of uric acid than subcutaneous fat obesity

Metabolism: Clinical and Experimental

Volumn 47, Issue 8, 1998, Pages 929-933

  Matsuura, Fumihiko ^a   Yamashita, Shizuya ^a   Nakamura, Tadashi ^a   Nishida, Makoto ^a   Nozaki, Shuichi ^a   Funahashi, Tohru ^a   Matsuzawa, Yuji ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GLUCOSE; INSULIN; TRIACYLGLYCEROL; URIC ACID;

ADULT; AGED; ARTICLE; BODY FAT; CLINICAL ARTICLE; HUMAN; HYPERURICEMIA; INSULIN RESISTANCE; LIPID METABOLISM; MALE; OBESITY; PRIORITY JOURNAL; RISK FACTOR; SUBCUTANEOUS FAT; SYNDROME X; TISSUE DISTRIBUTION; URINARY EXCRETION; VISCERA;

EID: 0031904638     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(98)90346-8     Document Type: Article

References (35)

1. Hollister LE, Overall JE, Snow HL, et al: Relationship of obesity to serum triglyceride, cholesterol, and uric acid and to plasma-glucose levels. Am J Clin Nutr 20:777-782, 1967
2. Krizek U: Serum uric acid in relation to body weight. Ann Rheum 25:456-458, 1966
3. Emmerson BT: Alteration of urate metabolism by weight reduction. Aust NZ J Med 3:410-412, 1973
4. Scott JR, Sturge RA: The effect of weight loss on plasma and urinary uric acid and lipid level. Adv Exp Med Biol 76B:274-277, 1977
5. Yamashita S, Matsuzawa Y, Tokunaga K, et al: Studies on the impaired metabolism of uric acid in obese subjects: Marked reduction of renal urate excretion and its improvement by a low-calorie diet. Int J Obes 10:255-264, 1986
6. Tokunaga K, Matsuzawa Y, Ishikawa K, et al: A novel technique for the determination of body fat by computed tomography. Int J Obes 7:437-445, 1983
7. Fujioka S, Matsuzawa Y, Tokunaga K, et al: Contribution of intraabdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity. Metabolism 36:54-59, 1987
8. Kanai H, Matsuzawa Y, Kotani K, et al: Close correlation of intraabdominal fat accumulation to hypertension in obese women. Hypertension 16:484-490, 1990
9. Nakajima T, Fujioka S, Tokunaga K, et al: Correlation of intraabdominal fat accumulation and left ventricular performance in obesity. Am J Cardiol 64:369-373, 1989
10. Jaffé M: Über den Niederschlag, Welchen Pikrinsäure innormalem Harnerzeugt und über eine neue Reaktion des Kleatinins. Hoppe Seyler Z Physiol Chem 10:391-400, 1986
11. Jiao S, Kameda K, Matsuzawa Y, et al: Hyperlipoproteinaemia in primary gout: Hyperlipoproteinaemic phenotype and influence of alcohol intake and obesity in Japan. Ann Rheum Dis 45:308-313, 1986
12. Yano K, Rhoads GG, Kagan A: Epidemiology of serum uric acid among 8000 Japanese-American men in Hawaii. J Chronic Dis 30:171-184, 1977
13. Reaven GM: Role of insulin resistance in human disease. Diabetes 37:1595-1607, 1988
14. Zimmet PZ: Kelly West Lecture 1991. Challenges in diabetes epidemiology - From west to the rest. Diabetes Care 15:232-252, 1992
15. Nakamura T, Tokunaga K, Shimomura I, et al: Contribution of visceral fat accumulation to the development of coronary artery disease in non-obese men. Atherosclerosis 107:239-246, 1994
16. Fujimoto WY, Newell-Morris LL, Grote M, et al: Visceral fat obesity and morbidity: NIDDM and atherogenic risk in Japanese-American men and women. Int J Obes 15:41-44, 1991
17. Després JP, Moorjani M, Ferland M, et al: Adipose tissue distribution and plasma lipoprotein levels in obese women: Importance of intraabdominal fat. Arteriosclerosis 9:203-210, 1989
18. Sparrow AD, Borkan GA, Gerzof SG, et al: Relationship of fat distribution to glucose tolerance: Results of computed tomography in male participants of the Normative Aging Study. Diabetes 35:411-415, 1986
19. Alfredo QG, Andrea N, Simona B, et al: Effect of insulin on uric acid excretion in humans. Am J Physiol 268:E1-E5, 1995
20. Francesco F, Chen YDI, Clarie BH, et al: Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration. JAMA 266:3008-3011, 1991
21. Modan M, Halkin H, Lusky A: Elevated serum uric acid - A facet of hyperinsulinemia. Diabetologia 30:713-718, 1987
22. Helena VM, Hennele YJ: Hyperuricemia and insulin resistance. J Clin Endocrinol Metab 78:25-29, 1994
23. Kissebah AH, Vydelingum N, Murray R, et al: Relation of body fat distribution to metabolic complications of obesity. J Clin Endocrinol Metab 54:254-260, 1982
24. Prager R, Wallace P, Olefsky JM, et al: In vivo kinetics of insulin action on peripheral glucose disposal and hepatic glucose output in normal and obese subjects. J Clin Invest 78:472-481, 1986
25. Golay A, Swislocki ALM, Chen YDI, et al: Effect of obesity on ambient plasma glucose, free fatty acid, insulin, growth hormone, and glucagon concentrations. J Clin Endocrinol Metab 63:481-484, 1986
26. Zuniga-Guajardo S, Jimenez J, Angel A, et al: Effects of massive obesity on insulin sensitivity and insulin clearance and the metabolic response to insulin as assessed by the euglycemic clamp technique. Metabolism 35:278-282, 1986
27. Matsubara K, Matsuzawa Y, Jiao S, et al: Relationship between hypertriglyceridemia and uric acid production in primary gout. Metabolism 38:698-701, 1989
28. Emmerson BT, Knowles BR: Triglyceride concentration in primary gout and gout of chronic lead nephropathy. Metabolism 20:721-729, 1971
29. Fox IH, John D, DeBruyne S, et al: Hyperuricemia and hypertriglyceridemia. Metabolic basis for the association. Metabolism 34:741-746, 1985
30. Carlson LA, Boberg J, Hogstedt B: Some physiological and clinical implications of lipid mobilization from adipose tissue, in Renold AE, Cahill GE (eds): Handbook of Physiology, Section 5, Adipose tissue. Baltimore, MD, Williams & Wilkins, 1965, pp 625-644
31. Kissebah AH, Alfarsi S, Adana PW, et al: Role of insulin resistance in adipose tissue in the pathogenesis of endogenous hypertri-glyceridemia in man. Diabetologia 12:563-571, 1976
32. Björntorp P: Portal adipose tissue as a generator of risk factors for cardiovascular disease and diabetes. Arteriosclerosis 10:493-496, 1990
33. Fox IH: Metabolic basis for disorders of purine nucleotide degradation. Metabolism 30:616-634, 1981
34. Fabreget I, Revilla E, Machado A: Short-term control of the pentose phosphate cycle by insulin could be modulated by NADPH/ NADP ratio in rat adipocytes and hepatocytes. Biochem Biophys Res Commun 142:920-925, 1987
35. Whitworth DA, Ratledge C: An analysis of intermediary metabolism and its control in a fat synthesizing yeast (Candida 107) growing on glucose or alkanes. J Gen Microbiol 88:275-288, 1975